Atlas Trials

Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer

Clinical trial NCT04906044 · UNKNOWN

Trial details

NCT number
NCT04906044
Sponsor
The First Hospital of Jilin University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
TislelizumabLocally Advanced Rectal CancerTotal Neoadjuvant TreatmentPD-1
Start date
2021-06-01
Primary completion
2023-10-18
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.